Anti-Bacterial, Anti-Viral, and Anti-Inflammatory Properties of Kumazasa Extract: A Potential Strategy to Regulate Smoldering and Inflammation
Authors:
- Hideki IwasakiHIHideki Iwasaki
- Shirol GulamSGShirol Gulam
- Tomoji MaedaTMTomoji Maeda
- Mineo WatanabeMWMineo Watanabe
- Tokuko TakajoTTTokuko Takajo
- Soh KatsuyamaSKSoh Katsuyama
- Hiroaki SanoHSHiroaki Sano
- Takanari TominagaTTTakanari Tominaga
- Akio OgawaAOAkio Ogawa
- Ken-Ichi SakoKSKen-Ichi Sako
- Toru TakahashiTTToru Takahashi
- Takahiro KawaseTKTakahiro Kawase
Open Access
Abstract
Background and Objectives: Kumazasa extract (KZExt) is a food product obtained by steam extraction of Kumazasa (Sasa senanensis and Sasa kurilensis) leaves under high temperature and pressure. It contains abundant polyphenols, including trans-p-coumaric acid and ferulic acid, as well as xylooligosaccharides. In this study, we investigated the antibacterial, anti-viral, and anti-inflammatory effects of KZExt in vitro and in vivo. Materials and Methods: The anti-oxidant, antibacterial, and anti-viral effects of KZExt were assessed in vitro. Anti-oxidant activity was evaluated based on the scavenging of •OH, •O2− and 1O2. Antibacterial effects were assessed by determining the minimum inhibitory concentration (MIC) using a microdilution method. Anti-influenza activity was measured via plaque formation in MDCK cells. Anti-inflammatory effects were assessed by measuring interleukin (IL)-1β inhibition in lipopolysaccharide (LPS)-stimulated RAW264.7 cells. In vivo, KZExt was administered once (30 min before) in a formalin-induced inflammation model to evaluate pain-related behavior. In the LPS-induced inflammation model, KZExt was administered for five days before LPS injection. Behavioral changes and cytokine levels were assessed 24 h later via the open field test and cytokine quantification. Results: In vitro, KZExt showed antibacterial, anti-influenza, and anti-oxidant effects, and suppressed LPS-induced IL-1β production. In vivo, it significantly reduced the second phase of formalin-induced pain behavior. In the LPS model, although behavioral changes were unaffected, KZExt suppressed IL-6 and interferon-γ production. Conclusions: The antibacterial, anti-viral, and anti-inflammatory effects of KZExt were confirmed in vitro and in vivo. Notably, the anti-inflammatory effect suggests potential immunomodulatory activity. These findings indicate that KZExt may help suppress smoldering inflammation and inflammation associated with various diseases through its combined antibacterial, anti-viral, and immunomodulatory actions.Keywords
Funding Information
- Raffinee International Inc
This publication has 26 references indexed in Scilit:
- Antibacterial properties and therapeutic potential of few medicinal plants: current insights and challengesDiscover Plants, 2025
- Chronic stress induces depression-like behavior in rats through affecting brain mitochondrial function and inflammationPsychoneuroendocrinology, 2024
- A rare olive compound oleacein functions as a TrkB agonist and mitigates neuroinflammation both in vitro and in vivoCell Communication and Signaling, 2024
- Antiviral Natural Products, Their Mechanisms of Action and Potential Applications as Sanitizers and DisinfectantsFood and Environmental Virology, 2023
- Role of cytokines and reactive oxygen species in brain agingMechanisms of Ageing and Development, 2023
- Consecutive intra-gingival injections of lipopolysaccharide and butyric acid to mice induce abnormal behavior and changes in cytokine concentrationsJournal of Neuroinflammation, 2020
- Interleukin-33 mediates formalin-induced inflammatory pain in miceNeuroscience, 2013
- Anti-inflammatory activity of cinnamon water extract in vivo and in vitro LPS-induced modelsBMC Complementary and Alternative Medicine, 2012
- Implications of reactive oxygen species and cytokines in gastroprotection against stress-induced gastric damage by nitric oxide releasing aspirinInternational Journal of Colorectal Disease, 2003
- Involvement of opioid receptors in the antinociception produced by intracerebroventricularly administered spantide in miceNeuropeptides, 1995